pivotal-therapeutics-inc
audio

Editeur

pivotal-therapeutics-inc

Publications

Pivotal Therapeutics cierra financiación
Category

Documents

Pivotal Therapeutics cierra financiación

Pivotal Therapeutics cierra financiación Alternate Text
Category

Documents

Médias

Pivotal Therapeutics cierra financiación

Book

7 pages

Flag

Español

icon play Lire
icon play Infos
Pivotal Therapeutics Closes Financing; Receives Over CDN $7.7 Million to Further VASCAZEN® Commercialization
Category

Documents

Pivotal Therapeutics Closes Financing; Receives Over CDN $7.7 Million to Further VASCAZEN® Commercialization

Pivotal Therapeutics Closes Financing; Receives Over CDN $7.7 Million to Further VASCAZEN® Commercialization Alternate Text
Category

Documents

Médias

Pivotal Therapeutics Closes Financing; Receives Over CDN $7.7 Million to Further VASCAZEN® Commercialization

Book

6 pages

Flag

English

icon play Lire
icon play Infos
Pivotal Therapeutics anuncia una Notificación de Aprobación para su formulación 6:1 EPA:DHA
Category

Documents

Pivotal Therapeutics anuncia una Notificación de Aprobación para su formulación 6:1 EPA:DHA

Pivotal Therapeutics anuncia una Notificación de Aprobación para su formulación 6:1 EPA:DHA Alternate Text
Category

Documents

Médias

Pivotal Therapeutics anuncia una Notificación de Aprobación para su formulación 6:1 EPA:DHA

Book

6 pages

Flag

Español

icon play Lire
icon play Infos
Pivotal Therapeutics Announces Notice of Allowance for U.S. Patent on its Unique 6:1 EPA:DHA Formulation
Category

Documents

Pivotal Therapeutics Announces Notice of Allowance for U.S. Patent on its Unique 6:1 EPA:DHA Formulation

Pivotal Therapeutics Announces Notice of Allowance for U.S. Patent on its Unique 6:1 EPA:DHA Formulation Alternate Text
Category

Documents

Médias

Pivotal Therapeutics Announces Notice of Allowance for U.S. Patent on its Unique 6:1 EPA:DHA Formulation

Book

5 pages

Flag

English

icon play Lire
icon play Infos
Respaldo positivo de Pivotal Therapeutics Inc. en el European Society of Cardiology Congress 2012
Category

Documents

Respaldo positivo de Pivotal Therapeutics Inc. en el European Society of Cardiology Congress 2012

Respaldo positivo de Pivotal Therapeutics Inc. en el European Society of Cardiology Congress 2012 Alternate Text
Category

Documents

Médias

Respaldo positivo de Pivotal Therapeutics Inc. en el European Society of Cardiology Congress 2012

Book

3 pages

Flag

Español

icon play Lire
icon play Infos
Pivotal Therapeutics Inc. Generates Positive Feedback at European Society of Cardiology Congress 2012
Category

Documents

Pivotal Therapeutics Inc. Generates Positive Feedback at European Society of Cardiology Congress 2012

Pivotal Therapeutics Inc. Generates Positive Feedback at European Society of Cardiology Congress 2012 Alternate Text
Category

Documents

Médias

Pivotal Therapeutics Inc. Generates Positive Feedback at European Society of Cardiology Congress 2012

Book

2 pages

Flag

English

icon play Lire
icon play Infos
Muestra de Pivotal Therapeutics en el European Society of Cardiology Congress 2012
Category

Documents

Muestra de Pivotal Therapeutics en el European Society of Cardiology Congress 2012

Muestra de Pivotal Therapeutics en el European Society of Cardiology Congress 2012 Alternate Text
Category

Documents

Médias

Muestra de Pivotal Therapeutics en el European Society of Cardiology Congress 2012

Book

2 pages

Flag

Español

icon play Lire
icon play Infos
Pivotal Therapeutics Exhibiting at European Society of Cardiology Congress 2012
Category

Documents

Pivotal Therapeutics Exhibiting at European Society of Cardiology Congress 2012

Pivotal Therapeutics Exhibiting at European Society of Cardiology Congress 2012 Alternate Text
Category

Documents

Médias

Pivotal Therapeutics Exhibiting at European Society of Cardiology Congress 2012

Book

2 pages

Flag

English

icon play Lire
icon play Infos
Pivotal anuncia una presentación científica en el 17th World Congress on Heart Disease
Category

Documents

Pivotal anuncia una presentación científica en el 17th World Congress on Heart Disease

Pivotal anuncia una presentación científica en el 17th World Congress on Heart Disease Alternate Text
Category

Documents

Médias

Pivotal anuncia una presentación científica en el 17th World Congress on Heart Disease

Book

3 pages

Flag

Español

icon play Lire
icon play Infos
Pivotal Announces Scientific Presentation at the 17th World Congress on Heart Disease Demonstrating Superiority of VASCAZEN™ Unique Formulation
Category

Documents

Pivotal Announces Scientific Presentation at the 17th World Congress on Heart Disease Demonstrating Superiority of VASCAZEN™ Unique Formulation

Pivotal Announces Scientific Presentation at the 17th World Congress on Heart Disease Demonstrating Superiority of VASCAZEN™ Unique Formulation Alternate Text
Category

Documents

Médias

Pivotal Announces Scientific Presentation at the 17th World Congress on Heart Disease Demonstrating Superiority of VASCAZEN™ Unique Formulation

Book

2 pages

Flag

English

icon play Lire
icon play Infos
  • Univers Univers
  • Ebooks Ebooks
  • Livres audio Livres audio
  • Presse Presse
  • Podcasts Podcasts
  • BD BD
  • Documents Documents
expand_more
Alternate Text